Experimental diabetes and left ventricular hypertrophy: Effects of beta-receptor blockade

Cardiovascular Pathology

Volumn 11, Issue 4, 2002, Pages 229-237

  Grimm, Daniela ^a   Jabusch, Hans C ^b   Kossmehl, Peter ^a   Huber, Michaela ^b   Fredersdorf, Sabine ^b   Griese, Daniel P ^b   Krämer, Bernhard K ^b   Kromer, Eckhard P ^c  

^a FREIE UNIVERSITÄT BERLIN   (Germany)

^b UNIVERSITY HOSPITAL REGENSBURG   (Germany)

^c GOETHE UNIVERSITY   (Germany)

Author keywords

adrenoceptor blocker; Extracellular matrix; Hypertrophy; Rats

Indexed keywords

BETA ADRENERGIC RECEPTOR; CARVEDILOL; COLLAGEN TYPE 1; FIBRONECTIN; LAMININ; STREPTOZOCIN; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CARBAZOLE DERIVATIVE; PROPANOLAMINE DERIVATIVE; SCLEROPROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BETA ADRENERGIC RECEPTOR BLOCKING; BLOOD PRESSURE; BODY WEIGHT; CONTROLLED STUDY; DISEASE ASSOCIATION; EXPERIMENTAL DIABETES MELLITUS; GENE OVEREXPRESSION; HEART LEFT VENTRICLE; HEART LEFT VENTRICLE HYPERTROPHY; HEART MUSCLE CELL; HEART MUSCLE FIBROSIS; HEART RATE; HEART WEIGHT; HYPERGLYCEMIA; MALE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; ANIMAL; HEART MUSCLE; METABOLISM; PATHOLOGY; WISTAR RAT;

ADRENERGIC BETA-ANTAGONISTS; ANIMAL; CARBAZOLES; DIABETES MELLITUS, EXPERIMENTAL; EXTRACELLULAR MATRIX PROTEINS; HYPERTROPHY, LEFT VENTRICULAR; MALE; MYOCARDIUM; PROPANOLAMINES; RATS; RATS, WISTAR; SUPPORT, NON-U.S. GOV'T; ANIMALS;

EID: 0036020634     PISSN: 10548807     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1054-8807(01)00116-8     Document Type: Article

References (41)

1. Diabetic cardiomyopathy
2. Diabetes and cardiovascular risk factors: The Framingham study
3. Diabetes mellitus and coronary heart disease
4. Diabetic cardiomyopathy: Pathophysiological and clinical aspects
5. Diabetes mellitus, hypertension and aging: The ionic hypothesis of aging and cardiovascular-metabolic diseases
6. 2+ in the heart during diabetes
7. Increased renal production of transforming growth factor-β1 in patients with type II diabetes
8. Left ventricular hypertrophy and its relation to the cardiac kinin-forming system in hypertensive and diabetic rats
9. Targeted overexpression of protein kinase C beta 2 isoform in myocardium causes cardiomyopathy
10. Effect of the ACE inhibitor lisinopril on mortality in diabetic patients with acute myocardial infarction: Data from the GISSI-3 study
11. Outcome of patients with diabetes mellitus and acute myocardial infarction treated with thrombolytic agents. The thrombolysis and angioplasty in myocardial infarction (TAMI) study group
12. The effect of diabetes mellitus on prognosis and serial left ventricular function after acute myocardial infarction: Contribution of both coronary disease and diastolic left ventricular dysfunction to the adverse prognosis. The MILIS study group
13. Prevalence of left ventricular hypertrophy in type I diabetic patients with diabetic nephropathy
14. Reciprocal changes in left-ventricular collagen alpha(1)-chain-gene-expression between type-I and type-IV in spontaneously diabetic rats
15. The effect of carvedilol on morbidity and mortality in patients with chronic heart failure
16. Cardioprotective potential of carvedilol
17. A potent antioxidant, SB209995 inhibits oxygen-radical mediated lipid peroxidation and cytotoxicity
18. The pharmacology of carvedilol
19. Blockade of the renin-angiotensin system in cardiac pressure-overload hypertrophy in rats
20. Effects of long-term angiotensin converting enzyme inhibition on myocardial hypertrophy in experimental aortic stenosis in the rat
21. Regulation of extracellular matrix proteins in pressure-overload cardiac hypertrophy: Effects of angiotensin-converting enzyme inhibition
22. Cardiac endothelin system impairs left ventricular function in renin-dependent hypertension via decreased sarcoplasmic reticulum Ca(2+) uptake
23. Development of heart failure following isoproterenol administration in the rat: Role of the renin-angiotensin system
24. Metabolic and cardiovascular effects of carvedilol and atenolol in non-insulin-dependent diabetes mellitus and hypertension - A randomized, controlled trial
25. Effects of acute oral beta adrenergic blockade on muscle blood flow in man
26. Noninvasive evaluation of cardiac dysfunction by echocardiography in streptozotocin-induced diabetic rats
27. New type of cardiomyopathy associated with diabetic glomerulosclerosis
28. Combined renovascular hypertension and diabetes in rats: A new preparation of congestive cardiomyopathy
29. Hypertensive-diabetic cardiomyopathy in rats
30. Diabetic cardiomyopathy
31. Effects of nisoldipine and lisinopril on left ventricular mass and function in diabetic nephropathy
32. Extracellular matrix proteins in cardiac fibroblasts derived from rat hearts with chronic pressure-overload: Effects of beta-receptor blockade
33. Angiotensin-converting enzyme inhibition prolongs survival and modifies the transition to heart failure in rats with pressure-overload hypertrophy due to ascending aortic stenosis
34. Hypertensive-diabetic cardiomyopathy in the rat. An experimental model of human disease
35. Carvedilol prevents severe hypertensive cardiomyopathy and remodeling
36. Effect of carvedilol in comparison with metoprolol on myocardial collagen postinfarction
37. Influence of angiotensin-converting enzyme inhibition by fosinopril on myocardial perfusion in streptozotocin-diabetic rats
38. Effects of ramipril on cardiovascular and microvascular outcomes in people with diabetes mellitus: Results of the HOPE study an MICRO-Hope substudy
39. Myocardial cell death in human diabetes